BART Cancer: a web resource for transcriptional regulators in cancer genomes is a dataset published in NAR Cancer (2021). On theSindex it has a DataRank of 0.382, placing it in the top 47.4% of the data-sharing corpus. It has been cited 6 times, with 6 citing works in its 1-hop citation network. Its calibrated FAIR score is 42/100.
Ranks in the top 47% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Full FAIR picture · advisory
The headline score is computed from the scored criteria — the fact-shaped checks (a repository, an accession, a licence) that two independent models agree on. The advisory criteria below are real FAIR guidance but rest on judgment calls that models read differently, so they inform without moving the number.
“http://bartcancer.org/”
The paper provides a web URL, not a persistent identifier from a PID scheme.
RDA-F1-01D — FAIR Data Maturity Model: 'Data is identified by a persistent identifier' (priorit · RDA-F1-02D — FAIR Data Maturity Model: 'Data is identified by a globally unique identifier' · FsF-F1-02D — F-UJI/FAIRsFAIR: 'Data is assigned a persistent identifier'
“BART Cancer database resource is available at http://bartcancer.org/ .”
The holder is a website (bartcancer.org), not a named data repository.
RDA-F4-01M — FAIR Data Maturity Model: metadata is offered so it can be harvested and indexed ( · NIH DMS Policy Element 4 (NOT-OD-21-014) — name the repository where data will be archived · NSTC Desirable Characteristics of Data Repositories (2022) — 'Long-Term Sustainability', 'Reten
“BART Cancer database resource is available at http://bartcancer.org/ .”
The dataset identifier (the URL) appears only in the body text (Data Availability section), not in the reference list.
FORCE11 Joint Declaration of Data Citation Principles (2014) — data should be cited as a first- · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes · FsF-F3-01M — F-UJI: 'Metadata includes the identifier of the data it describes'
Advisory · not in the published score
“BART Cancer database resource is available at http://bartcancer.org/ .”
The statement points to a URL (a web resource) rather than a repository record with an accession, so it is a link to archived data but not a repository record.
Colavizza, Hrynaszkiewicz, Staden, Whitaker & McGillivray (2020), 'The citation advantage of li · Springer Nature research data policy — Data Availability Statements: standard statement templat · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes
“BART Cancer integrates over 10000 gene expression profiling RNA-seq datasets from TCGA with over 7000 ChIP-seq datasets from the Cistrome Data Browser database and the Gene Expression Omnibus (GEO).”
The dataset is described in running prose, not in an itemised inventory (section, table, or list). [majority verdict 'partial' (4/5 passes agreed)]
RDA-F2-01M — 'Rich metadata is provided to allow discovery' (priority Essential) · FsF-F2-01M — F-UJI: 'Metadata includes descriptive core elements to support data findability' · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data'
“BART Cancer database resource is available at http://bartcancer.org/ .”
The route to the data is a public URL with no stated precondition.
RDA-A1.1-01D — 'Data is accessible through a free access protocol' · FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · NSTC Desirable Characteristics of Data Repositories (2022) — 'Free and Easy Access'
Advisory · not in the published score
“The results, figures, and differentially expressed genes are all freely available for download.”
The paper explicitly states that the data are 'freely available for download', which is a label of open access.
FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · RDA-A1-01M — metadata contains information to enable the user to get access to the data · COAR Controlled Vocabularies — Access Rights v1.0 (open / embargoed / restricted / metadata-onl
The data are not sensitive or human-subject (aggregated from public sources), and no gatekeeper is named.
NIH Genomic Data Sharing Policy (NOT-OD-14-124) — controlled-access via a Data Access Committee · RDA-A1.2-01D — 'Data is accessible through an access protocol that supports authentication and · NIH DMS Policy Element 5 (NOT-OD-21-014) — Access, Distribution, or Reuse Considerations (conse
The paper neither states how long the data will persist nor gives a timing of availability beyond 'available now'.
NIH DMS Plan Element 4 (NOT-OD-21-014) — Data Preservation, Access, and Associated Timelines · NSTC Desirable Characteristics (2022), Organizational Infrastructure: 'Retention Policy' · RDA-A2-01M — 'Metadata is guaranteed to remain available after data is no longer available'
No file format is named for the released data.
FsF-R1.3-02D — F-UJI: 'Data is available in a file format recommended by the target research co · RDA-R1.3-02D — data is expressed in a machine-understandable community standard · RDA-I1-01D — data uses a knowledge representation expressed in a standardised format
Advisory · not in the published score
No data or metadata community standard is named for the data.
RDA-R1.3-01M — 'Metadata complies with a community standard' (priority Essential) · RDA-R1.3-01D — 'Data complies with a community standard' · RDA-I2-01M — '(Meta)data use vocabularies that follow FAIR principles'
No identifier for external resources (e.g., TCGA dataset accession) is provided.
RDA-I3-01M — '(meta)data include references to other (meta)data' · RDA-I3-03M — 'metadata includes qualified references to other metadata' · FsF-I3-01M — F-UJI: 'Metadata includes links between the data and its related entities'
No license artefact is named for the data; the CC BY license applies to the article only.
RDA-R1.1-01M — 'Metadata includes information about the licence under which the data can be reu · RDA-R1.1-02M — 'Metadata refers to a standard reuse licence' · RDA-R1.1-03M — 'Metadata refers to a machine-understandable reuse licence'
No version token or date is given for the data snapshot.
DataCite Metadata Schema 4.6 — the 'Version' property · RDA-R1.2-01M — provenance information (which version was used is provenance) · NSTC Desirable Characteristics of Data Repositories (2022) — 'Provenance', 'Retention Policy'
The study's own code (for BART Cancer) is not deposited or given a locator.
NIH DMS Policy Element 2 (NOT-OD-21-014) — 'Related Tools, Software and/or Code' · FAIR4RS Principles v1.0 (Chue Hong et al., 2022; RDA/FORCE11/ReSA) — FAIR Principles for Resear · FORCE11 Software Citation Principles (Smith, Katz & Niemeyer, 2016, PeerJ CS 2:e86)
“National Institutes of Health [R35GM133712 to C.Z.].”
The paper provides a specific award number (R35GM133712) attached to a named funder.
DataCite Metadata Schema 4.6 — 'FundingReference' property (funderName, funderIdentifier, award · Crossref Funder Registry — canonical funder identifiers for funding metadata · RDA-F2-01M — rich metadata provided to allow discovery (funding is part of the descriptive reco
Advisory · not in the published score
“BART version 2.0 was used to generate TR prediction results for both up-regulated and down-regulated gene lists derived from each cancer type.”
The paper names the specific software (BART version 2.0) and tool (DESeq2) used to produce the data.
RDA-R1.2-01M — 'Metadata includes provenance information according to community- specific standa · FsF-R1.2-01M — F-UJI: 'Metadata includes provenance information about data creation or generati · W3C PROV-O (W3C Recommendation, 2013) — the entity/activity/agent model of provenance
“The table is displayed with the following columns: TR, name of transcriptional regulator; Wilcoxon test statistic, Wilcoxon rank-sum test comparing the set of association score from one TR with all the association scores. The higher the test score is, the more likely the TR regulates the input; Wilcoxon P-value, One-sided P-value of the Wilcoxon rank-sum test. The smaller the P-value is, the more significant the TR regulates the input; Z-score, Z-score indicates the deviation of the TR’s Wilcoxon test score from its background model, which is generated from MSigDB gene sets. The background model contains the Wilcoxon test score for each TR and each gene set; Max AUC, Maximum association score of each TR in its datasets indicating the specific binding pattern of one dataset that has the highest correlation with the input; Relative Rank, Rank indicating average between Wilcoxon P-value, Z-score, and maximum association score and then dividing the absolute rank by the total number of TRs; and Irwin-Hall P-value, indicating the rank significance, the smaller the P-value is, the more significant the rank is.”— not found in the paper; verdict downgraded
The paper defines the variables (columns of the BART result table) in the body of the article, but no separate documentation object (README, codebook) is said to accompany the data. [downgraded to 'no' — no verifiable quote from the paper] [majority verdict 'no' (3/5 passes agreed)]
RDA-R1-01M — '(Meta)data are richly described with a plurality of accurate and relevant attribu · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data' · NIH DMS Policy Element 3 (NOT-OD-21-014) — Standards (documentation and metadata to accompany t
Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0.0898
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
National Institutes of Health
Grant: R35GM133712
FWCI
0.24
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords